Medical education is highlighted as a key strategy to address the underuse and misuse of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation.
Nonvalvular atrial fibrillation (NVAF) is the most frequent cause of cardioembolic stroke. Due to the aging of the population, NVAF is becoming an important public health issue. Despite the impressive results of trials with oral anticoagulation (OAC) in primary and secondary prevention of stroke in NVAF patients, OAC remains underused or misused in practice. Beyond the risk of bleeding, there also are several arguments for a lack of knowledge about trials and guidelines. Medical education could then be one of the most effective way to improve stroke prevention in NVAF patients in practice.
No takes yet. Share an insight, caveat, or question.
Deplanque et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: